Chris Abell
28PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (28)
Sort by Publication Date:
|Jul 14, 2025
Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism.Madeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert
|Aug 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents.Simon R Stockwell, Duncan E Scott, Gerhard Fischer
|Mar 22, 2024
Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference.Jamal El Bakali, Michal Blaszczyk, Joanna C Evans
|Feb 09, 2023
Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference.Jamal El Bakali, Michal Blaszczyk, Joanna C Evans
|Jun 01, 2022
Potential therapeutic targets from Mycobacterium abscessus (Mab): recently reported efforts towards the discovery of novel antibacterial agents to treat Mab infections.William Addison, Martyn Frederickson, Anthony G Coyne
|Apr 22, 2022
Author Correction: Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles.Sara Abalde-Cela, Patricia Taladriz-Blanco, Marcelo Ganzarolli de Oliveira
Pageof 5
Frequent Collaborators
15 joint publications
Anthony G Coyne
7 joint publications
Vitor Mendes
5 joint publications
Helena I M Boshoff
5 joint publications
Ziyi Yu
4 joint publications
Valerie Mizrahi
4 joint publications
Christina Spry
3 joint publications
Weiguang Seetoh
3 joint publications
Joanna C Evans
3 joint publications
Marcio V B Dias
3 joint publications
Tom L Blundell
